REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
GCC RNTCP - Greater Chennai Corporation Revised National Tuberculosis Control Programme Chennai, Tamil Nadu, India.
PLoS One. 2020 Nov 4;15(11):e0241203. doi: 10.1371/journal.pone.0241203. eCollection 2020.
Tuberculosis prevalence surveys have demonstrated the benefit of screening with chest x-ray (CXR) and sensitive diagnostic tests compared to symptoms and smear microscopy. However, in programmatic practice there is little evidence on the yield of different algorithms. We implemented contact tracing in Chennai, India for adult sputum-positive TB patients registered from January 2015 to March 2016. Patients with symptoms or abnormal X-ray findings further underwent testing using Xpert MTB/RIF (Xpert) and smear microscopy. A retrospective cohort study was done to summarize the key findings. We verbally screened 5553 contacts for symptoms, CXR through private sector collaboration, Xpert, and smear microscopy. Overall, 1312 (23.6%) contacts screened positive. CXR alone identified 531 (40.5%) of them, 679 (51.8%) were symptom-positive only, while 102 (7.8%) were positive on both the symptom and CXR screen. Overall, 35 bacteriologically positive cases were identified (0.7%). A standard approach of symptoms screening followed by microscopy identified only 9 (25.7%) of the total number of bacteriologically positive cases, whereas the combination of a CRX screening followed by microscopy identified 13 (37.1%) of the cases. The algorithm of symptoms screening followed by Xpert testing, detected 20 cases, whereas the combination of symptoms and CXR followed by Xpert increased this number to 35 (75% increase compared to symptoms and Xpert). Optimal use of more sensitive screening tests, better diagnostic tests, and novel private sector engagement can improve diagnostic yield in a programmatic setting.
结核病患病率调查表明,与症状和涂片显微镜检查相比,胸部 X 光(CXR)和敏感诊断检测筛查具有优势。然而,在规划实践中,关于不同算法的效果的证据很少。我们在印度钦奈实施了针对成人痰阳性结核病患者的接触者追踪,这些患者是在 2015 年 1 月至 2016 年 3 月期间登记的。有症状或 X 线异常发现的患者进一步接受 Xpert MTB/RIF(Xpert)和涂片显微镜检查。进行了一项回顾性队列研究来总结主要发现。我们通过私营部门合作,口头筛查了 5553 名接触者的症状、CXR、Xpert 和涂片显微镜检查。共有 1312 名(23.6%)接触者筛查阳性。仅 CXR 就发现了 531 名(40.5%),679 名(51.8%)仅为症状阳性,而 102 名(7.8%)在症状和 CXR 筛查中均为阳性。总体而言,确定了 35 例细菌学阳性病例(0.7%)。采用标准的症状筛查方法结合显微镜检查仅发现了总细菌学阳性病例的 9 例(25.7%),而 CXR 筛查结合显微镜检查发现了 13 例(37.1%)。症状筛查后进行 Xpert 检测的算法检测到了 20 例,而症状和 CXR 筛查后进行 Xpert 检测则将该数字增加到了 35 例(与症状和 Xpert 相比增加了 75%)。优化使用更敏感的筛查检测、更好的诊断检测以及新型私营部门参与可以提高规划环境中的诊断效果。